Skip to content
PPRX × Zooki: liposomal vitamins, electrolytes and collagen, chosen for life on a GLP-1. Shop the range.
Foundayo 0.8 mg (orforglipron) tablets with PPRX pharmacy packaging

Foundayo tablet.

TrustScore 4.9/5119 reviews

Orforglipron — a GLP-1 medicine in a once-daily tablet you can take at any time of day, with or without food. No needles, no fridge, no waiting to eat. Prescribed where clinically appropriate by a UK prescriber.

Foundayo with PPRX — the private prescription, clinical review and free next working day delivery are all part of one price.

Select a dose

Select a plan

£114.99£124.99

for the 0.8 mg dose · per pack · 30 tablets, a 30-day supply

You save £10 on every order

Prescription-only
Check my eligibility

Includes prescription, clinical review & delivery · Subject to clinical consultation

What is Foundayo?

Foundayo is orforglipron, a GLP-1 receptor agonist made as a small-molecule tablet rather than an injected peptide. It's a prescription medicine for adults with obesity, or with overweight and a weight-related health problem, used alongside a reduced-calorie diet and more physical activity to lose weight and keep it off.

What sets it apart from other GLP-1 tablets is the routine: one tablet a day, whenever suits you, with or without food and with no restrictions on water. Like the injectable GLP-1s, it starts at a low dose and steps up gradually so your body has time to adjust.

Active ingredient

Orforglipron

Class

GLP-1 agonist

Cadence

Once daily

Dose range

0.8–17.2 mg

Form

Oral tablet

From

£124.99 / mo

Benefits that go further than weight.

Orforglipron is a GLP-1 tablet with no food or water rules — and in trials its benefits reached past the scale, to the heart-health markers your clinician watches.

Take it any time of day

A 24-hour dial with a glowing marker and a tablet at the centre

One tablet a day, with or without food, and no rules about water.

Improves heart-health markers

Three sliders, blood pressure, triglycerides and cholesterol, all moved toward healthy

In trials, blood pressure, triglycerides and cholesterol improved alongside weight loss.1

A small molecule, not a peptide

A grey peptide chain breaking apart beside an intact glowing blue ring molecule

Orforglipron survives digestion on its own, so it doesn't need an empty stomach to work.

1As part of a balanced diet and healthy lifestyle.

How Foundayo works.

Orforglipron switches on the same GLP-1 receptor as semaglutide — but it's a small molecule, not a peptide, so it survives digestion without special handling.

The molecule

orforglipron

once daily tablet

GLP-1one target
GLP-1receptor

Curbs appetite, slows stomach emptying, and tells the brain you're full for longer.

⟶

Because the tablet doesn't need an empty stomach to be absorbed, there's no morning ritual to plan around — one tablet, any time of day, with or without food or drink.

What to expect

Honest about side effects.

Nausea, vomiting and diarrhoea are most likely when you start or step up a dose, and generally ease with time. Smaller meals, blander food, less fat and plenty of fluids all help — and each dose is held for at least 30 days before moving up.

Common & usually mild

  • Nausea
  • Constipation
  • Diarrhoea
  • Vomiting
  • Indigestion
  • Stomach pain
  • Headache

Rare & serious

Stomach problems can sometimes be severe, and fluid loss from vomiting or diarrhoea can lead to dehydration and kidney problems. Foundayo must not be taken by anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, and should not be combined with another GLP-1 medicine.

Always read the patient information leaflet. This page is information, not a substitute for the clinical advice you'll receive in your consultation.

A daily tablet, tested over 72 weeks.

Numbers come from the registration trial, not marketing averages — and only ever happen alongside diet, activity and clinical follow-up.

11.1%

average body-weight reduction at the 17.2 mg dose

72 wks

trial duration

2.1%

average reduction with placebo in the same trial

72-week study of orforglipron vs placebo in adults without diabetes; average loss was 7.4% at 5.5 mg, 8.3% at 9 mg and 11.1% at 17.2 mg. Results vary; achieved alongside diet and activity.

Your projection

What Foundayo could mean for you.

Set the slider to where you are today and watch the trial average become actual kilograms — with medication and support, versus the same trial's group who had lifestyle changes alone.

An illustration, not a promise — your prescriber sets real expectations.

You, today

98kg

on the trial average, −10.9 kg

98kg96kg−2.1%87kg−11.1%Start17 months later
Foundayo + PPRX support (trial average)Without medication
Illustrative curve from the average outcomes in 72-week study (orforglipron 17.2 mg vs placebo, adults without diabetes). “Without medication” is the trial’s placebo group, who received lifestyle support only. Individual results vary — losing 10.9 kg is not guaranteed.

Started low, stepped up gently.

Everyone begins at the lowest dose and moves up roughly monthly. This titration is the single biggest reason side effects stay manageable — and your prescriber adjusts the pace to you.

Month 1

0.8 mg

Starting dose — lets your body adjust

Month 2

2.5 mg

Month 3

5.5 mg

Month 4

9 mg

Month 5

14.5 mg

Maintenance

up to 17.2 mg

Held at the dose that suits you

Foundayo price in the UK, by dose

Your dose usually increases during titration, so the price rises with it. Each price is per pack (30 tablets, a 30-day supply) and includes the prescription, clinical review and delivery.

Foundayo 0.8 mg (orforglipron) tablets with PPRX pharmacy packaging
Foundayo 0.8 mg£124.99 per pack
DosePrice per pack

All sales are subject to prescriber approval following a free online consultation.

Prescribed, titrated, delivered.

One all-in price per pack — the medication, the private prescription, clinical review and free next working day delivery. The consultation is free, and a subscription is optional — Subscribe & Save for £10 off every order, or order one-off.

  • Reviewed by a UK-registered prescriber
  • Discreet, next working day — no needles, no fridge
  • Subscribe & Save or order one-off — no lock-in
FoundayoPrescription-only
£124.99/mo · from
Active ingredientorforglipron
CadenceOnce daily
Dose range0.8–17.2 mg
Check if it's right for you

Subject to clinical consultation

A PPRX delivery box being picked up from the doorstep
DeliveredNext working day · free

Everything, for one price.

Your Foundayo price is all-in — the medicine and the care around it, with nothing bolted on afterwards.

Check my eligibility

The genuine medication

Genuine, UK-licensed medicine dispensed by our GPhC-registered UK pharmacy.

Private prescription included

A UK-registered prescriber reviews your consultation before anything is dispensed — the prescription is part of the price.

Clinical review

Every order is checked by our pharmacy team, with ongoing support as your dose changes.

Free next working day delivery

Tracked, discreet packaging, delivered free the next working day — no fridge required.

Pharmacist support

Message our pharmacy team whenever you have a question about your treatment.

Your choice of plan

Subscribe for monthly delivery — £10 off every order of Mounjaro or Wegovy pens, Foundayo or Alli — or order one-off. Pause or cancel anytime.

Foundayo
questions.

The questions we hear most about Foundayo. Anything else, write to info@pprx.co.uk.

How much does Foundayo cost?
From £124.99 for a pack of 30 tablets at the 0.8 mg starting dose, rising with each step up to £199.99 at 17.2 mg. Every price includes the private prescription, clinical review and free next working day delivery, and Subscribe & Save takes £10 off every order.
What is Foundayo?
Foundayo is the brand name for orforglipron, a once-daily GLP-1 tablet made by Eli Lilly. It's a prescription medicine for weight management in adults with obesity, or with overweight and a weight-related health problem, alongside diet and physical activity.
Do I have to take it on an empty stomach?
No. Foundayo can be taken at any time of day, with or without food, and with no restrictions on water. Swallow the tablet whole — don't break, crush or chew it — and take no more than one tablet a day.
How much weight do people lose on Foundayo?
In a 72-week study of adults without diabetes, average weight loss was 11.1% at the highest dose (17.2 mg), compared with 2.1% for placebo. Lower doses averaged 7.4% (5.5 mg) and 8.3% (9 mg). Individual results vary.
How is Foundayo different from the Wegovy Pill?
Both are once-daily GLP-1 tablets, but they're different medicines. The Wegovy Pill is oral semaglutide and has to be taken on an empty stomach with a 30-minute wait before eating. Foundayo is orforglipron and has no food or water rules.
Do I have to start at the lowest dose?
Yes. Everyone starts at 0.8 mg and stays on each dose for at least 30 days before stepping up. Your prescriber sets the pace, and you can stay at any dose that's working for you.
Can I switch to Foundayo from another weight-loss medicine?
Often, yes. Tell us what you've taken, at what dose and how you got on, and your prescriber will decide whether Foundayo suits you and where to start. Foundayo must not be taken alongside another GLP-1 medicine.

Medically reviewedThis Foundayo page is reviewed by Omar Kadir, Superintendent Pharmacist, MPharm (GPhC 2078291). For full prescribing and safety information, see the patient information leaflet supplied with your medicine or the electronic medicines compendium.

Start your free consultation.

Three minutes of your time, reviewed by a UK-registered prescriber. No commitment and no charge for the consultation. If treatment is approved, it arrives free the next working day.

  • 4.9Trustpilot
  • 9012740GPhC register
  • £0Consultation
Begin consultation